Rosuvastatin inhibit the cell proliferation and the expression of angiogenic factors Vascular Endothelial Growth Factor and Matrix-Metalloproteinase-9 in DU-145 human prostate cancer cells
Open Access
- 11 May 2021
- journal article
- Published by Peertechz Publications Private Limited in International Journal of Immunotherapy and Cancer Research
- Vol. 7 (1), 008-014
- https://doi.org/10.17352/2455-8591.000031
Abstract
No abstract availableThis publication has 26 references indexed in Scilit:
- Potentiating NK cell activity by combination of Rosuvastatin and Difluoromethylornithine for effective chemopreventive efficacy against Colon CancerScientific Reports, 2016
- The current evidence on statin use and prostate cancer prevention: are we there yet?Nature Reviews Urology, 2016
- Role of Matrix Metalloproteinases in Photoaging and PhotocarcinogenesisInternational Journal of Molecular Sciences, 2016
- Rosuvastatin Induces ROS-mediated Apoptosis in Human Prostate Cancer PC-3 CellsJournal of Life Science, 2016
- VEGF expression in pancreatic cancer and other malignancies: a review of the literatureRomanian Journal of Internal Medicine, 2015
- Effect of Rosuvastatin on Arginase Enzyme Activity and Polyamine Production in Experimental Breast CancerBalkan Medical Journal, 2015
- Physiology and pathophysiology of matrix metalloproteasesAmino Acids, 2010
- Pleiotropic effects of statins and related pharmacological experimental approachesMethods and Findings in Experimental and Clinical Pharmacology, 2006
- Vascular Endothelial Growth Factor and AngiogenesisPharmacological Reviews, 2004
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001